Abstract Details
|
Chetan P. Gandhy, MD
(Eli Lilly)
PRESENTER |
No disclosure on file |
| Gabriela A. Bou, MD (Emory University School of Medicine) | Dr. Bou has nothing to disclose. |
| Muhammad H. Jaffer, MD | Dr. Jaffer has nothing to disclose. |
| Kristen L. Zemina, MD | Dr. Zemina has nothing to disclose. |
| Karl A. Kasischke, MD | No disclosure on file |
| Robert Myers, DO (Mount Sinai) | No disclosure on file |
| No disclosure on file | |
| Theresa A. Zesiewicz, MD (University of South Florida) | Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. |